RxDoctor Payments Data

Rudolph Leibel

Pediatrics · New York, NYNPI 1891972402

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $43,758 of the $67,407 with a category attached, or 64.9%. 9 manufacturers reported payments, led by Pfizer at 31.9% of the total. Reporting peaked in 2019 at $17,103 and has fallen 52.9% since, to $8,061 in 2025. Among pediatrics clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$67,407in general payments, 2019–2025

Across 28 payments — averaging $2407.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$22K
  • Eli Lilly$13K
  • Merck$12K
  • AbbVie$7K
  • Janssen Research & Development, LLC$5K
  • Boehringer Ingelheim International GmbH$5K
  • plus $5K from 3 others
$975,377in research payments, 2019–2025

Across 4 payments — averaging $243,844 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi$899K
  • Regeneron$76K

What the payments were for

  • Consulting fees$43,75865%
  • Speaking & faculty fees$9,10014%
  • Grants$11,90518%
  • Travel & lodging$2,1603%
  • Food & beverage$4831%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$67,407 in reported general payments places this provider in the 95th percentile of 4,055 pediatrics providers in New York.

See all pediatrics providers in New York

Other pediatrics in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →